Nutritional Growth Solutions Ltd (ASX:NGS) is an Australian consumer nutrition company focused on products designed for children’s nutritional needs. The company markets nutrition products including Healthy Height and other children-focused offerings. This article examines the company’s acquisition strategy, product portfolio and the factors shaping …
Biotron Limited (ASX:BIT) is an Australian biotechnology company developing antiviral therapies. The company’s lead programme, BIT225, is focused on targeting viral proteins associated with persistent infections. This article examines Biotron’s research approach, BIT225 development pathway and the factors influencing future progress.
Vectus Biosystems Limited (ASX:VBS) is a clinical-stage healthcare company developing VB0004, an investigational anti-fibrotic drug candidate. The company is focused on addressing fibrosis, a process involving the formation of scar tissue that can affect organ function. This article examines the VB0004 programme, clinical development …
Island Pharmaceuticals Ltd (ASX:ILA) is a clinical-stage antiviral biotechnology company focused on developing treatments for viral infections. The company's lead programme, galidesivir, is a small-molecule antiviral candidate being evaluated for potential use against high-consequence viral diseases. This article reviews the company's antiviral strategy, development …
Prescient Therapeutics Limited (ASX:PTX) is a Melbourne-based clinical-stage oncology company developing targeted cancer therapies. The company's lead programme, PTX-100, is being evaluated for cutaneous T-cell lymphoma, a rare form of blood cancer. This article reviews PTX-100's development pathway, clinical progress and the factors shaping …
OncoSil Medical Limited (ASX:OSL) is an Australian medical device company focused on targeted radiation treatment for pancreatic cancer. Its OncoSil device is designed to deliver radioactive phosphorus-32 particles directly into tumours through an image-guided procedure. This article reviews the company's technology, clinical progress and …
Imagion Biosystems Limited (ASX:IBX) is a medical imaging company developing technology designed to identify cancer-related biological signals using magnetic nanoparticles. Its MagSense platform combines nanoparticles with targeting molecules to support molecular imaging applications. This article examines the company's technology approach, clinical development progress and …
Actinogen Medical Limited (ASX:ACW) is a clinical-stage biotechnology company focused on developing therapies for neurological conditions. The company’s lead programme, Xanamem, is an experimental oral medicine designed to inhibit the 11-beta-HSD1 enzyme and investigate the role of cortisol regulation in brain health. This article …
AdAlta Limited (ASX:1AD) is a clinical-stage biotechnology company developing therapeutics based on its i-body platform. The technology is designed to create targeted protein therapeutics that may address biological targets that are difficult for conventional antibody approaches to reach. This article reviews AdAlta’s technology platform, …
Anatara Lifesciences Ltd (ASX:ANR) is an Australian healthcare company focused on developing products in areas including gut health and weight management. The company is exploring an oral candidate aimed at supporting weight control after the use of weight-loss treatments. This article reviews Anatara’s development …